Apexigen

Apexigen

Biotechnology Research

San Carlos, California 1,444 followers

Creating Transformative Immunotherapies for Patients with Cancer

About us

Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer. Its lead immuno-oncology drug candidate, sotigalimab, is a potent immune-activating antibody against CD40 currently in Phase 2 clinical development.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
San Carlos, California
Type
Public Company

Locations

  • Primary

    75 Shoreway Road Suite C

    San Carlos, California 94070, US

    Get directions

Employees at Apexigen

Similar pages

Browse jobs

Funding

Apexigen 6 total rounds

Last Round

Post IPO equity

US$ 2.8M

See more info on crunchbase